This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
WAS Gene Therapy
Drug Names(s): WAS Gene Therapy
Description: Genethon's treatment for Wiskott-Aldrich syndrome consists of autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene.
WAS Gene Therapy News
Additional information available to subscribers only: